Search results for “Segmental Ileitis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 41 patents, we discovered top 25 key players by total patent application. Aventis Pharma, Ono Pharmaceutical Co., Ltd., Merck Serono SA are dominant in this area. They take 24.39% of the total patent filing.
Aventis Pharma
Belgium
Patent: 4
Ono Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 3
Merck Serono SA
Vaud, Switzerland
Patent: 3
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 2
Mitsubishi Tanabe Pharma Corp.
Osaka-fu, Japan
Patent: 2
LEO Pharma A/S
Hovedstaden, Denmark
Patent: 2
Sanwa Kagaku Kenkyusho Co., Ltd.
Aichi-ken, Japan
Patent: 2
Telik, Inc.
California, United States
Patent: 2
Aventis Pharma SARL
France
Patent: 2
Yeda Research & Development Co. Ltd.
Israel
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 4 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 1
Shenyang Pharmaceutical University
Liaoning Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: